Slava Epstein is an American academic, researcher and entrepreneur working in the field of Microbial ecology. He is currently a professor in the biology department of Northeastern University and co-founder of NovoBiotic Pharmaceuticals. As a researcher his most covered contribution is the development of the Isolation chip (iChip) and the discovery of a new antibiotic, Teixobactin. Epstein's research has been published in many leading scientific journals including Nature and Science.
Slava Epstein | |
|---|---|
| Nationality | Russian |
| Occupation(s) | Researcher, academic, entrepreneur. |
| Academic background | |
| Education | M.S., Marine Biology (1981) Ph.D., Microbial Ecology (1986) |
| Alma mater | Moscow State University Shirshov Institute of Oceanology |
| Academic work | |
| Institutions | Northeastern University |
| Website | https://cos.northeastern.edu/people/slava-epstein-2/ |
Early life edit
Slava Epstein was born in the Soviet Union in a Jewish family. As a kid he was fascinated with astronomy and dreamed of being a physicist, however due to strict Soviet anti-semitic quotas he was advised to switch to biology.[1]
Education edit
Slava Epstein received an M.S. in marine biology from Moscow State University in 1981 and PhD in microbial ecology from the Russian Academy of Sciences, Shirshov Institute of Oceanology in 1986.[2] For his research he traveled to the White Sea to study protozoan organisms.[3]
Immigration to the United States edit
Epstein immigrated with his family from the Soviet Union in late 1980's.[4] He first volunteered, then completed a postdoc at the University of Massachusetts, Boston.[5] Since 1992, he has worked at Northeastern University, where he is a professor in the biology department. [6]
Career edit
His main field of research is microbial ecology along with cultivation and discovery of previously unculturable microorganisms. Along with Kim Lewis, he is credited with development of the Isolation Chip (iChip).[7] He was on the team along with Kim Lewis that discovered a previously unknown antibiotic Teixobactin, by screening soil bacteria using novel cultivation methods, particularly by cultivating the Eleftheria terrae, the antibiotic-producing bacteria in soil, which is the organism's natural environment.[8]
Awards and honors edit
Foreign Policy Magazine Leading Global Thinkers 2015, along with Kim Lewis. For the discovery of antibiotic Taixobactin in a pile of dirt.[9]
Bibliography edit
- Epstein SS, ed. (2009). Uncultivated Microorganisms. Microbiology Monographs. Vol. 10. Springer. doi:10.1007/978-3-540-85465-4. ISBN 978-3-540-85464-7. S2CID 250023301.
References edit
- ^ "The Dark Matter - from space to biology and back | Slava Epstein | TEDxBratislava". YouTube.
- ^ "Slava Epstein".
- ^ "Miracle Microbes". The New Yorker.
- ^ "Indiana Jones- style professor explores frontiers of microbial science".
- ^ "A radically simple idea may open the door to a new world of antibiotics".
- ^ "Slava Epstein".
- ^ "Use of ichip for high-throughput in situ cultivation of "uncultivable" microbial species". Applied and Environmental Microbiology. Apr 2010: 76 (8) 2445-2450.
- ^ Ling, L. L.; Schneider, T.; Peoples, A. J.; Spoering, A. L.; Engels, I.; Conlon, B. P.; Mueller, A.; Schäberle, T. F.; Hughes, D. E.; Epstein, S.; Jones, M.; Lazarides, L.; Steadman, V. A.; Cohen, D. R.; Felix, C. R.; Fetterman, K. A.; Millett, W. P.; Nitti, A. G.; Zullo, A. M.; Chen, C.; Lewis, K. (2015). "A new antibiotic kills pathogens without detectable resistance". Nature. 517 (7535): 455 − 459 (2015). Bibcode:2015Natur.517..455L. doi:10.1038/nature14098. PMC 7414797. PMID 25561178.
- ^ "FP Leading Global Thinkers 2015, Healers".
This article needs additional or more specific categories. (January 2021) |